Alkermes execs say they’re flummoxed by embarrassing FDA drug refusal; stock plunges
April 02, 2018 at 10:50 AM EDT
The regulator said it wouldn’t even review the company’s depression drug application, saying there wasn’t enough evidence that it worked.